[1]
Y. Miura, “Clinical experience with pirfenidone in five patients with scleroderma-related interstitial lung disease”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 31, no. 3, pp. 235–238, Oct. 2014, Accessed: Aug. 21, 2025. [Online]. Available: https://mail.mattioli1885journals.com/index.php/sarcoidosis/article/view/3326